Trends in gestational choriocarcinoma: A 27‐year perspective

Obstetrics and Gynecology

Volumn 102, Issue 5, 2003, Pages 978-987

  Smith, Harriet O ^a   Qualls, Clifford R ^a   Prairie, Beth A ^a   Padilla, Luis A ^a   Rayburn, William F ^a   Key, Charles R ^a  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANALYTIC METHOD; CANCER MORTALITY; CANCER REGISTRY; CANCER RISK; CANCER SURVIVAL; CHORIOCARCINOMA; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA ANALYSIS; DISEASE SEVERITY; EPIDEMIOLOGICAL DATA; EVALUATION; FEMALE; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; NONBIOLOGICAL MODEL; POISSON DISTRIBUTION; POPULATION RESEARCH; PREGNANCY; PRIORITY JOURNAL; RACE; RECORDING; REVIEW; RISK ASSESSMENT; SURVIVAL RATE; SURVIVAL TIME; TIME; UNITED STATES;

EID: 0242543056     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1016/s0029-7844(03)00669-0     Document Type: Article

References (40)

1. Berkowitz RS, Goldstein DP. Chorionic tumors [review]. N Engl J Med 1996;335:1740-8.
2. Lage JM, Wolf NG. Gestational trophoblastic disease. New approaches to diagnosis. Clin Lab Med 1995;15:631-64.
3. Aziz MF, Kampono N, Moegni EM, Sjamsuddin S, Barnas B, Samil RS. Epidemiology of gestational trophoblastic neoplasm at the Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia. Adv Exp Med Biol 1984;176:165-75.
4. Palmer JR. Advances in the epidemiology of gestational trophoblastic disease. J Reprod Med 1994;39:155-62.
5. Brinton LA, Bracken MB, Connelly RR. Choriocarcinoma incidence in the United States. Am J Epidemiol 1986;123:1094-100.
6. Hertig AT, Mansell H. Tumors of the female sex organs, part I: Hydatidiform mole and choriocarcinoma. In: Atlas of tumor pathology, section IX, fascicle 33. Washington: Armed Forces Institute of Pathology, 1956.
7. Shanmugaratnam K, Muir CS, Tow SH, Cheng WC, Christine B, Pedersen E. Rates per 100,000 births and incidence of choriocarcinoma and malignant mole in Singapore Chinese and Malays: Comparison with Connecticut, Norway, and Sweden. Int J Cancer 1971;8:165-75.
8. Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Porkin DM, Whelan S, Van Holten V, Muir C, eds. International classification of diseases for oncology (ICD-0), 3rd ed. Geneva: World Health Organization, 2000.
9. Cunningham J, Ries L, Hankey B, Seiffert J, Lyles B, Shambaugh E, et al, eds. The SEER program code manual, revised edition. National Institutes of Health (PHS) 92-1999. Bethesda, Maryland: National Institutes of Health, 1999.
10. Smith PG. Comparison between registries: Age-standardized rates. In: Parkin DM, Muir CS, Whelan SL, Gao Y-T, Ferlay J, Powel J, eds. Cancer incidence in five continents, vol. VI (IARC scientific publication no. 120). Lyon, France: IARC, 1992.
11. Kleinbaum DG, Kupper LL, Muller KE. Applied regression analysis and other multivariate methods. North Sciutate, Massachusetts: Duxbury Press, 1988.
12. McCullagh P, Nelder JA. Generalized linear models, 2nd ed. London: Chapman & Hall, 1989.
13. Collett D. Modelling survival data in medical research. London: Chapman & Hall, 1994.
14. Kalbfleisch JD, Prentice RL. The statistical analysis of failure time data. New York: John Wiley & Sons, 1980.
15. Saraiya M, Berg CJ, Shulman H, Green CA, Atrash HK. Estimates of the annual number of clinically recognized pregnancies in the United States, 1981-1991. Am J Epidemiol 1999;149:1025-9.
16. Hayashi K, Bracken MB, Freeman DH Jr, Hellenbrand K. Hydatidiform mole in the United States (1970-1977): A statistical and theoretical analysis. Am J Epidemiol 1982; 15:67-77.
17. Yen S, MacMahon B. Epidemiologic features of trophoblastic disease. Am J Obstet Gynecol 1968;101:126-32.
18. Westerhout FC Jr, Morel ES, Slate WG. Observations on 138 molar pregnancies. Am J Obstet Gynecol 1969;103:56-9.
19. Massad LS, Abu-Rustum NR, Less SS, Renta V. Poor compliance with postmolar surveillance and treatment protocols by indigent women. Obstet Gynecol 2000;96:940-4.
20. Dignam JJ. Differences in breast cancer prognosis among African-American and Caucasian women. CA Cancer J Clin 2000;50:50-64.
21. Hicks ML, Phillips JL, Parham G, Andrews N, Jones WB, Shingleton HM, et al. The National Cancer Data Base report on endometrial carcinoma in African-American women. Cancer 1998;83:2629-37.
22. Digman JJ, Ye Y, Colangelo L, Smith R, Manounas EP, Wieand HS, et al. Prognosis after rectal cancer in blacks and whites participating in adjuvant therapy randomized trials. J Clin Oncol 2003;21:413-20.
23. Howell EA, Chen YT, Concato J. Differences in cervical cancer mortality among black and white women. Obstet Gynecol 1999;94:509-15.
24. Grisby PW, Hall-Daniels L, Baker S, Perez CA. Comparison of clinical outcome in black and white women treated with radiotherapy for cervical carcinoma. Gynecol Oncol 2000;79:357-61.
25. Cross CK, Harris J, Recht A. Race, socioeconomic status, and breast carcinoma in the U.S.: What have we learned from clinical studies. Cancer 2002;95:1988-99.
26. O'Malley CD, Le GM, Laser SL, Shema SJ, West DW. Socioeconomic status and breast carcinoma survival in four racial/ethnic groups. Cancer 2003;97:1303-11.
27. Katz SJ, Hofer TP. Socioeconomic disparities in preventive care persist despite universal coverage: Breast and cervical cancer screening in Ontario and the United States. JAMA 1994;272:530-4.
28. Bagshawe KD, Dent J, Webb J. Hydatidiform mole in England and Wales 1973-1983. Lancet 1986;11:673-7.
29. Flam F, Lindsted-Lundström V, Rutqvist LE. Incidence of gestational trophoblastic disease in Stockholm county, 1975-1988. Eur J Epidemiol 1992;8:173-7.
30. Marquez-Monter H, de la Vega GA, Ridaura C, Robles M. Gestational choriocarcinoma in the general hospital of Mexico: Analysis of forty cases. Cancer 1968;22:91-8.
31. Aguero O, Kizer S, Pinedo G. Hydatidiform mole in Concepcion Palacios Maternity Hospital. Am J Obstet Gynecol 1973;116:1117-20.
32. Martin PM. Hydatidiform mole in Nigeria, Iran, and Alaska. III. High frequency of hydatidiform mole in native Alaskans. Int J Gynaecol Obstet 1978;15:395-6.
33. Smith HO, Hilgers RD, Bedrick EJ, Qualls CR, Wiggins CL, Rayburn RF, et al. Ethnic differences in risk for gestational trophoblastic disease in New Mexico: A 25-year population-based study. Am J Obstet Gynecol 2003;188:357-66.
34. Kim SJ, Bae SN, Kim JH, Kim CJ, Han KT, Chung JK, et al. Epidemiology and time trends of gestational trophoblastic disease in Korea. Int J Gynecol Obstet 1998;60:S33-8.
35. Hando T, Ohno M, Kurose T. Recent aspects of gestational trophoblastic disease in Japan. Int J Gynecol Obstet 1998;60:S71-6.
36. Sakumoto K, Kigashi M, Kanazawa K. Hydatidiform mole in Okinawa Islands and mainland Japan. Int J Gynaecol Obstet 1999;64:309-10.
37. Sivanesartnam V. The management of gestational trophoblastic disease in developing countries such as Malaysia. Int J Gynaecol Obstet 1998;60:S105-9.
38. McCorriston CC. Racial incidence of hydatidiform mole. Am J Obstet Gynecol 1968;101:377-82.
39. Matsuura J, Chiu D, Jacobs PA, Szulman AE. Complete hydatidiform mole in Hawaii: An epidemiological study. Genetic Epidemiol 1984;1:271-84.
40. Herts BR, Yee JM, Porges RF. Primary cervical choriocarcinoma: Case report and review of the literature. J Ultrasound Med 1993;12:59-62.